Primary ovarian insufficiency

There are 90 papers on primary ovarian insufficiency in aging research: 4 trials and 33 observational studies in people, 9 in animals, 40 reviews. The newest story, Oct 18, 2026: “Genetic patterns varied with menstrual history in Utah women”.

Disease

90 papers study it30 more mention it43 findings

MeSH

3 new papers in 30 daysSee all 120 papers on primary ovarian insufficiency

“This relationship was maintained after adjustment for confounders (adjusted OR [aOR], 2.0; 95% CI, 1.5-2.5).”
The association between primary ovarian insufficiency and increased multimorbidity in a large prospective cohort (Canadian Longitudinal Study on Aging)Fertility and sterility2024doi:10.1016/j.fertnstert.2024.08.345
  • Human trial4
  • Humans33
  • Animals9
  • In silico2

Effects

5

Family size

no changein humans1downin humans1

1 study
  1. Primary ovarian insufficiency was not clearly linked with family size in humans (relatives of women with POI vs relatives of controls).

    “There were no differences in the number of children born to relatives of women with POI, including those with familial POI.”

    Humansrelatives of women with POI vs relatives of controls

    Family size for women with primary ovarian insufficiency and their relatives

    Human reproduction (Oxford, England)

  2. Primary ovarian insufficiency is linked with lower family size in humans (women diagnosed 1995 to 2021) (median 1 less).

    “Approximately 14% fewer women with POI will have children, but for those able to have children the median number is 1 less than for age-matched controls.”

    Humanswomen diagnosed 1995 to 2021females

    Family size for women with primary ovarian insufficiency and their relatives

    Human reproduction (Oxford, England)

Menopause Impact Scale

upin humans1

1 study
  1. Primary ovarian insufficiency is linked with higher Menopause Impact Scale in humans after age adjustment compared to other menopause etiologies.

    “After age adjustment, symptom burden was highest in primary ovarian insufficiency, with the largest differences in vasomotor and genitourinary domains.”

    Humansafter age adjustment compared to other menopause etiologiesfemales

    Menopause impact questionnaire validated in US women

    Maturitas

More on Menopause Impact Scale

Fertility

downin humans1

1 study
  1. Primary ovarian insufficiency impairs fertility in humans.

    “Primary ovarian insufficiency (POI) is a disease that significantly affects the fertility, mental health, and physical health of up to 3.5% of women.”

    Reviewfemales

    Primary ovarian insufficiency diagnosis, treatment, and sequelae: current evidence

    Current opinion in obstetrics & gynecology

Reproductive lifespan

downin humans1

1 study
  1. Primary ovarian insufficiency shortens reproductive lifespan in humans.

    “These mechanisms converge on core cellular processes, driving premature follicular depletion and shortening reproductive lifespan.”

    Reviewfemales

    From Genes to Lives: Integrating the Complexities of Primary Ovarian Insufficiency

    International journal of molecular sciences

Telomere length

downin humans1

1 study
  1. Primary ovarian insufficiency is linked with lower telomere length in humans (non-iatrogenic hypergonadotropic hypogonadism).

    “Females with POI due to estrogenic deficiency have slightly shorter mean telomere length (10,0 [7,9-10,7] kB, than healthy females of reproductive age (10,8 [10,0-13,1] кБ, р<0,001).”

    Humansnon-iatrogenic hypergonadotropic hypogonadismleukocytesfemalesn = 33

    Replicative and biochemical ageing features among females with primary ovarian insufficiency

    Problemy endokrinologii

More on Telomere length

Associations

36

Telomere length

downin humans2OR 0.54

2 studies
  1. Primary ovarian insufficiency is associated with telomere length in humans.

    “telomere length within premutation carriers was not associated with repeat length but was associated with a diagnosis of FXPOI”

    Humansfemales

    Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length

    American journal of medical genetics. Part A

  2. Primary ovarian insufficiency is associated with telomere length in humans after adjusting for age (0.75 ± 0.09 vs 1.79 ± 0.12, P < 0.001; OR = 0.54, 95% CI = 0.43-0.68).

    “patients with biochemical POI (n = 120) exhibited significantly shorter LTLs”

    Humansafter adjusting for ageperipheral blood leukocytesfemales

    Impaired telomere length and telomerase activity in peripheral blood leukocytes and granulosa cells in patients with biochemical primary ovarian insufficiency

    Human reproduction (Oxford, England)

More on Telomere length

Low polygenic risk score for age at natural menopause

upin humans1

1 study
  1. Low polygenic risk score for age at natural menopause is associated with primary ovarian insufficiency in humans (women carrying rare variants; polygenic risk score below -0.5 standard deviation).

    “low PGS (<-0.5 standard deviation) compounded POI risk in a subset of women carrying rare variants.”

    Humanswomen carrying rare variants; polygenic risk score below -0.5 standard deviationfemales

    Genetic patterns varied with menstrual history in Utah women

    Journal of the Endocrine Society

More on Low polygenic risk score for age at natural menopause

Thyroid, adrenal and polyglandular autoimmune disorders

upin humans1

1 study
  1. Thyroid, adrenal and polyglandular autoimmune disorders are associated with primary ovarian insufficiency in humans.

    “Autoimmune associations are most consistently described in relation to thyroid, adrenal, and polyglandular autoimmune disorders”

    Review

    Genetic and autoimmune factors in primary ovarian insufficiency

    Research Connections

More on Thyroid, adrenal and polyglandular autoimmune disorders

FMR1

upin humans1

1 study
  1. FMR1 is associated with primary ovarian insufficiency in humans.

    “Genetic studies have identified established and candidate abnormalities involving chromosomes, FMR1, folliculogenesis, meiosis, DNA repair, and mitochondrial function”

    Review

    Genetic and autoimmune factors in primary ovarian insufficiency

    Research Connections

More on FMR1

Gonadotropin-releasing hormone agonists

downin humans1RR 0.16

1 study
  1. Gonadotropin-releasing hormone agonists lower the risk of primary ovarian insufficiency in humans during cyclophosphamide therapy (RR 0.16, 95% CI 0.07-0.37).

    “Premature ovarian insufficiency occurred in 5 of 93 women receiving gonadotropin-releasing hormone agonists and in 28 of 69 controls, corresponding to a risk ratio of 0.16 (95% confidence interval (CI): 0.07-0.37).”

    Reviewduring cyclophosphamide therapyfemalesn = 162

    Gonadotropin-releasing hormone agonists during cyclophosphamide for ovarian protection in systemic lupus erythematosus

    Reproduction & fertility

More on Gonadotropin-releasing hormone agonists

Endometriosis

upin humans1

1 study
  1. Endometriosis is linked with a higher risk of primary ovarian insufficiency in humans (versus propensity-score-matched comparison group without endometriosis) (3.7x risk).

    “Patients with endometriosis had a 3.7x the risk of primary ovarian insufficiency and 12.4x the risk of surgical menopause (p < 0.0001)”

    Humansversus propensity-score-matched comparison group without endometriosisfemales

    Rates of premature ovarian insufficiency and surgical menopause in patients with endometriosis

    Journal of gynecology obstetrics and human reproduction

More on Endometriosis

Alzheimer's disease

upin humans1

1 study
  1. Primary ovarian insufficiency raises the risk of Alzheimer's disease in humans.

    “reproductive disorders such as primary ovarian insufficiency (POI) and polycystic ovary syndrome (PCOS) are associated with deficits in cognitive performance, altered DMN dynamics, and increased AD risk.”

    Review

    Gonadotropins Across the Lifespan: Their role in the Neurodevelopment-Neurodegeneration Continuum

    The Yale journal of biology and medicine

More on Alzheimer's disease

Systemic accelerated aging

upin humans1

1 study
  1. Primary ovarian insufficiency is associated with systemic accelerated aging in humans.

    “Primary ovarian insufficiency (POI) affects up to 3% of reproductive-aged women and is a critical yet underrecognized contributor to infertility and systemic accelerated aging.”

    Reviewfemales

    From Genes to Lives: Integrating the Complexities of Primary Ovarian Insufficiency

    International journal of molecular sciences

DLK1

upin humans1

1 study
  1. Primary ovarian insufficiency is associated with DLK1 in humans (primary ovarian insufficiency).

    “We also detected the upregulation of DLK1 in granulosa cells from patients with primary ovarian insufficiency.”

    Humansprimary ovarian insufficiencygranulosa cells

    Spatial Transcriptomic Characteristics of the Aging Human Ovary

    Aging cell

More on DLK1

Anti-Müllerian hormone

downin humans1

1 study
  1. Anti-Müllerian hormone predicts primary ovarian insufficiency in humans (secondary oligomenorrhea) (85% sensitivity, 100% specificity).

    “In cases of primary ovarian insufficiency (POI), AMH levels are significantly reduced, aiding in diagnosis and distinguishing POI from other causes of amenorrhea.”

    Reviewsecondary oligomenorrhea< 8 pmol/Lfemales

    The role of anti-Müllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction

    Endocrine

More on Anti-Müllerian hormone

All 36

Trial sponsors

Funding

2 grants since 2019

National Institute of Child Health and Human Development$2.8M

Latest

Dec 2025: 1Jan 2026: 5Feb 2026: 3Mar 2026: 2Apr 2026: 3May 2026: 3Jun 2026: 1Jul 2026: 3Aug 2026: 3Sep 2026: 1Oct 2026: 6Nov 2026: 233 papers in 12 months
Journal of the Endocrine Society

Genetic patterns varied with menstrual history in Utah women

Among 899 women with primary ovarian insufficiency, 32.1% had Turner syndrome, a condition involving a missing or incomplete X chromosome.Among 899 women with primary ovarian insufficiency, 32.1% had Turner syndrome, a condition involving a missing or incomplete X chromosome.

Genetic association · 68 peoplePopulations
Maturitas

Menopause impact questionnaire validated in US women

A 22-question measure covering seven symptom areas was supported by three online studies of 2,915 US women aged 21–85.A 22-question measure covering seven symptom areas was supported by three online studies of 2,915 US women aged 21–85.

Cross-sectional study of 2,915 peopleBiomarkers

See all 120 papers on primary ovarian insufficiency